These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12741592)

  • 21. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia].
    Onoue H; Matsunobu A; Nagaishi A; Yukitake M; Kuroda Y
    Rinsho Shinkeigaku; 2004 Jan; 44(1):20-4. PubMed ID: 15199733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contraindications and complications with the use of botulinum toxin.
    Klein AW
    Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance.
    Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A
    Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iatrogenic botulism in an amateur weight-lifter.
    Duffey P; Brown C
    Mov Disord; 2006 Jul; 21(7):1056. PubMed ID: 16639740
    [No Abstract]   [Full Text] [Related]  

  • 27. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC; Rodrigues B; Torres AC; Enzo A; Melo A
    J Neurol Sci; 2007 Feb; 253(1-2):85-7. PubMed ID: 17229441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altering brow contour with botulinum toxin.
    Chen AH; Frankel AS
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):457-64. PubMed ID: 15062250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuralgic amyotrophy following botulinum toxin injection.
    Alcalay RN; Simões RM; Feigin A; Frucht S
    Parkinsonism Relat Disord; 2010 May; 16(4):301-2. PubMed ID: 19815448
    [No Abstract]   [Full Text] [Related]  

  • 30. Patients' perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury.
    Hori S; Patki P; Attar KH; Ismail S; Vasconcelos JC; Shah PJ
    BJU Int; 2009 Jul; 104(2):216-20. PubMed ID: 19220255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation].
    Arner M; Himmelmann K; Pontén E; Stankovic N; Hansson T; Dahlin LB
    Lakartidningen; 2008 Oct 22-28; 105(43):3009-13. PubMed ID: 19024613
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Botulinum neurotoxin A: an unusual systemic effect 43 (2007) 499-501.
    Scheinberg A; O'Flaherty S; Waugh MC; Baxter A; Gurd K
    J Paediatr Child Health; 2008; 44(7-8):468-9; author reply 469. PubMed ID: 18638338
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2008 Feb; 101(4):515-6; author reply 516-7. PubMed ID: 18234066
    [No Abstract]   [Full Text] [Related]  

  • 35. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F; Cocuzza M; Gomes CM; Leão N
    Neurourol Urodyn; 2008; 27(4):311-4. PubMed ID: 17914742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
    de Ru JA; Buwalda J
    J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Will suburothelial injection of small dose of botulinum A toxin have similar therapeutic effects and less adverse events for refractory detrusor overactivity?
    Kuo HC
    Urology; 2006 Nov; 68(5):993-7; discussion 997-8. PubMed ID: 17113890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New procedures in facial plastic surgery using botulinum toxin A.
    Stupak HD; Maas CS
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):515-20. PubMed ID: 15062256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.